Skip to main content
    I

    Incyte Corporation (INCY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $120.27
    -0.70 (-0.58%)

    Market Cap: $24.66B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Incyte Corporation (INCY) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    Incyte reported revenue of $5.14B for the fiscal year ended Dec 31, 2025, up 21.2% from the year before. That year, net income was $1.29B with a net margin of 25.0%, operating cash flow was $1.41B and free cash flow was $1.35B. The quarter ended Sep 30, 2026 had revenue of $1.56B and net income of -$784.80M.

    Revenue and Margins

    The operating margin was 29.5% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $1.11B, a compound annual rate of 18.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$5.14B+21.2%92.8%29.5%25.0%
    Dec 2024$4.24B+14.8%92.6%1.4%0.8%
    Dec 2023$3.70B+8.9%93.1%16.8%16.2%
    Dec 2022$3.39B+13.7%93.9%17.1%10.0%
    Dec 2021$2.99B+12.0%94.9%19.6%31.8%
    Dec 2020$2.67B+23.5%95.1%-9.9%-11.1%
    Dec 2019$2.16B+14.7%94.7%18.6%20.7%
    Dec 2018$1.88B+22.5%95.0%6.9%5.8%
    Dec 2017$1.54B+38.9%94.8%-15.8%-20.4%
    Dec 2016$1.11BN/A94.7%13.1%9.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 3854.6% from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$5.14B$4.24B$3.70B$3.39B$2.99B$2.67B$2.16B$1.88B$1.54B$1.11B
    Cost of revenue$372.13M$312.07M$254.99M$207.00M$150.99M$131.33M$114.25M$94.12M$79.48M$58.19M
    Gross profit$4.77B$3.93B$3.44B$3.19B$2.84B$2.54B$2.04B$1.79B$1.46B$1.05B
    Research and development$2.05B$2.61B$1.63B$1.59B$1.46B$2.22B$1.15B$1.20B$1.33B$581.86M
    Operating income$1.51B$61.37M$620.52M$579.44M$585.78M-$263.68M$402.01M$129.22M-$243.39M$145.00M
    Net income$1.29B$32.62M$597.60M$340.66M$948.58M-$295.70M$446.91M$109.49M-$313.14M$104.22M
    EBITDA$1.63B$163.42M$717.12MN/A$654.27M-$188.66M$508.72M$215.95M-$174.06M$203.42M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.56B$1.67B$1.27B$1.51B$1.37B$1.22B$1.05B$1.18B$1.14B$1.04B$880.89M$1.01B
    Gross profit$1.45B$1.57B$1.17B$1.39B$1.27B$1.14B$979.71M$1.09B$1.05B$967.13M$819.93M$943.59M
    Operating income-$708.36M$697.90M$301.12M$335.86M$443.52M$530.31M$205.17M$301.51M$146.09M-$478.13M$91.90M$187.27M
    Net income-$784.80M$585.61M$303.33M$299.28M$424.17M$405.00M$158.20M$201.21M$106.46M-$444.60M$169.55M$201.08M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $41.14M by $3.06B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$6.96B$5.44B$6.78B$5.84B$4.93B$3.56B$3.43B$2.65B$2.30B$1.64B
    Current assets$5.02B$3.24B$4.65B$4.09B$3.12B$2.36B$2.48B$1.83B$1.50B$994.18M
    Cash and equivalents$3.10B$1.69B$3.21B$2.95B$2.06B$1.51B$1.83B$1.16B$899.51M$652.34M
    Total liabilities$1.79B$2.00B$1.59B$1.47B$1.16B$949.65M$828.34M$719.79M$671.95M$1.22B
    Short-term debt$41.14M$39.24M$38.42M$36.54M$37.01M$38.40M$52.34M$31.84M$34.24M$19.54M
    Long-term debtN/A$33.54M$29.16M$30.08M$31.63MN/A$18.30M$17.43M$16.61M$651.48M
    Shareholder equity$5.17B$3.45B$5.19B$4.37B$3.77B$2.61B$2.60B$1.93B$1.63B$419.47M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$7.29B$7.87B$7.34B$6.96B$6.33B$5.82B$5.75B$5.44B$5.01B$4.66B$7.14B$6.78B
    Total liabilities$1.64B$1.53B$1.72B$1.80B$1.68B$1.65B$2.08B$2.00B$1.84B$1.66B$1.74B$1.59B
    Cash and equivalents$3.28B$3.98B$3.46B$3.10B$2.46B$1.95B$1.94B$1.69B$1.30B$987.29M$3.35B$3.21B
    Shareholder equity$5.64B$6.34B$5.62B$5.17B$4.65B$4.17B$3.67B$3.45B$3.17B$3.00B$5.39B$5.19B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 95.7% of operating cash flow. Share repurchases came to 1.4% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$1.41B$335.34M$496.49M$969.94M$749.49M-$124.60M$710.66M$336.23M-$92.99M$304.76M
    Capital expenditures$58.87M$86.26M$32.49M$77.83M$181.01M$187.38M$78.06M$73.48M$111.02M$120.28M
    Free cash flow$1.35B$249.07M$464.00M$892.11M$568.48M-$311.98M$632.59M$262.74M-$204.01M$184.48M
    Dividends paidN/AN/AN/A$26.30M$29.94M$22.76M$16.75MN/A$0$0
    Share repurchases$19.10M$2.00B$0$0N/AN/AN/AN/AN/AN/A
    Investing cash flow-$102.61M$157.52M-$207.68M-$78.54M-$207.70M-$269.00M-$87.45M-$86.42M-$349.98M-$232.49M
    Financing cash flow$101.04M-$2.02B-$20.03M-$794.00K$6.18M$71.71M$45.71M$14.66M$690.21M$44.62M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$675.32M$507.66M$369.35M$543.30M$559.39M$44.74M$266.07M$381.22M$310.87M-$575.56M$218.81M$147.73M
    Capital expenditures$15.63M$12.41M$10.20M$21.88M$14.75M$19.07M$3.17M$17.38M$5.19M$54.14M$9.55M$2.27M
    Free cash flow-$690.95M$495.25M$359.15M$521.42M$544.64M$25.67M$262.90M$363.83M$305.68M-$629.71M$209.26M$145.46M
    Last 12 quarters

    Frequently Asked Questions About INCY

    What is Incyte's annual revenue?

    Incyte reported revenue of $5.14B for the fiscal year ended Dec 31, 2025.

    How fast is Incyte's revenue growing?

    Revenue was up 21.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 14.8%.

    Is Incyte profitable?

    Yes. Incyte reported net income of $1.29B for the fiscal year ended Dec 31, 2025, with a net margin of 25.0%.

    How much free cash flow does INCY generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.41B minus capital expenditures of $58.87M produced free cash flow of $1.35B.

    How much debt does Incyte have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $41.14M and cash and equivalents of $3.10B.